Is Prophylactic Intravenous Administration of a Proton Pump Inhibitor Necessary for Perioperative Management of Cardiac Surgery?

Authors

  • Kishu Fujita
  • Mitsumasa Hata
  • Akira Sezai
  • Hisakuni Sekino
  • Kazutomo Minami

DOI:

https://doi.org/10.1532/HSF98.20111162

Abstract

Background: Mortality from gastrointestinal (GI) hemorrhage caused by antiplatelet or anticoagulant therapy (or both) is quite high after cardiac surgery. We previously reported that proton pump inhibitor (PPI) therapy is indispensable in preventing postoperative GI complications. PPIs are usually administered intravenously immediately after surgery and subsequently by oral formulations. We conducted a prospective study to evaluate whether intravenous PPI followed by oral administration is more efficient as prophylaxis than oral-only administration.

Methods and Results: We enrolled 40 patients scheduled to undergo coronary artery bypass grafting with cardiopulmonary bypass and randomly assigned them to receive oral PPIs alone (group 1) or intravenous PPI followed by oral administration (group 2). Postoperative upper GI endoscopy evaluations showed no evidence of GI bleeding. Only gastritis, esophagitis, and hiatal hernia were observed at similar incidences in the groups. Mean hospital stays were also similar, but the cost of PPI treatment was significantly lower in group 1.

Conclusion: No additional benefits of intravenous PPIs over oral formulations were demonstrated. Oral PPIs alone were effective and economical as prophylaxis against GI complications. Intravenous PPIs might be unnecessary in selected patients after cardiac surgery.

References

Aranha GV, Pickleman J, Pifarre R, Scanlon PJ, Gunnar RM. 1984. The reasons for gastrointestinal consultation after cardiac surgery. Am Surg 50:301-4.nBhatt DL, Scheiman J, Abraham NS, et al. 2008. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 52:1502-17.nD'Ancona G, Baillot R, Poirier B, et al. 2003. Determinants of gastrointestinal complications in cardiac surgery. Tex Heart Inst J 30:280-5.nFilsoufi F, Rahmanian PB, Castillo JG, Sculock C, Legnani PE, Adams DH. 2007. Predictors and outcome of gastrointestinal complications in patients undergoing cardiac surgery. Ann Surg 246:323-9.nGlance LG, Osler TM, Mukamel DB, Dick AW. 2007. Effect of complications on mortality after coronary artery bypass grafting surgery: evidence from New York State. J Thorac Cardiovasc Surg 134:53-8.nHalm U, Halm F, Thein D, Mohr FW, Mö<>ssner. 2000. Helicobactor pylori infection: a risk factor for upper gastrointestinal bleeding after cardiac surgery. Crit Care Med 28:110-3.nHata M, Shiono M, Sekino H, et al. 2005. Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery. Circ J 69:331-4.nHata M, Shiono M, Sekino H, et al. 2006. Efficacy of a proton pump inhibitor given in the early postoperative period to relieve symptoms of hiatal hernia after open heart surgery. Surg Today 36:131-4.nJavid G, Zargar SA, U-Saif R, et al. 2009. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer. J Gastroenterol Hepatol 24:1236-43.nRodriguez F, Nguyen TC, Galanko JA, Morton J. 2007. Gastrointestinal complications after coronary artery bypass grafting: a national study of morbidity and mortality predictors. J Am Coll Surg 205:741-7.nvan der Voort PH, Zandstra DF. 2000. Pathogenesis, risk factors, and incidence of upper gastrointestinal bleeding after cardiac surgery: is specific prophylaxis in routine bypass procedures needed? J Cardiothorac Vasc Anesth 14:293-9.nZacharias A, Schwann TA, Parenteau GL, et al. 2000. Predictors of gastrointestinal complications in cardiac surgery. Tex Heart Inst J 27:93-9.n

Published

2012-10-23

How to Cite

Fujita, K., Hata, M., Sezai, A., Sekino, H., & Minami, K. (2012). Is Prophylactic Intravenous Administration of a Proton Pump Inhibitor Necessary for Perioperative Management of Cardiac Surgery?. The Heart Surgery Forum, 15(5), E277-E279. https://doi.org/10.1532/HSF98.20111162

Issue

Section

Articles